More from this employer
Bothell, USA
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor
Bothell, USA
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor
Bothell, USA
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor
Bothell, USA
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor
Bothell, USA
Bothell, USA
Bothell, USA
Bothell, USA
Bothell, USA
Bothell, USA
Bothell, USA
Bothell, USA
Bothell, USA
Bothell, USA
Base Career helps you apply smarter for this job.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies.
We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates.
Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S.
FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy.
We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.
The Director, Program Management is a hands-on program manager responsible for driving cross-functional planning and execution across two assets at different stages of development.
First, this role will serve as the program manager for our first ADC program as it transitions from early to late-stage development, building the integrated development plan, operating cadence, and governance infrastructure required to carry the asset forward.
Second, this role will support an early-stage asset within our radiopharmaceutical portfolio, serving as both the program manager and the CMC project manager from candidate selection through IND-enabling activities and early clinical evaluation.
This is a broad role that spans the development lifecycle and calls for a program manager who can drive stage-gate readiness for a maturing program while establishing the plans and processes that set an emerging one up for success. Reporting to the Senior Vice President of Project and Program Management, the successful candidate will partner closely with Research, Nonclinical, CMC, Clinical Development, Clinical Operations, Regulatory Affairs, Quality, and external partners to translate program strategy into actionable plans, align teams to the critical path, and provide decision-ready reporting to governance forums and senior leadership. This position will also contribute to evolving the program management operating model, tools, and templates to support a growing pipeline.
ADC Program Management – Early to Late-Stage Transition
Documentation and Compliance
Knowledge and Skills
$214,962 — $242,116 USD
Immunome, Inc. is an equal opportunity employer.
We celebrate diversity and are committed to creating an inclusive environment for all employees.
Immunome, Inc. is a participant in E-Verify.
Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Public clinical-stage biotechnology company developing targeted oncology therapies for cancer patients.
Visit company websiteSkip the repetitive application forms
Install the Base Career Chrome Extension and autofill job applications across major job boards with your profile.
Trusted by over 500,000 job seekers on Base Career